Treating opioid addiction in primary care helps patients and cash-strapped medical practices

November 10, 2020

Buprenorphine-based treatment for opioid addiction is in short supply in many areas of the United States. And while many physicians want to offer it, clinics are unsure how to offer buprenorphine therapy in a financially sustainable way. A team of researchers at Harvard Medical School conducted financial cost and revenue analysis for four different approaches to delivering buprenorphine-based treatment in primary care practices. The approaches differed based on who in the clinic delivered the majority of face-to-face care, the presence of nurse care managers, and whether care was delivered in traditional one-on-one or group settings.

Microsimulation modelling found that all four approaches to care produced positive net revenue after the first year, and net revenues were consistently highest for rural practices. Physician-led treatment and shared medical visits, both of which relied on nurse care managers, consistently produced the greatest net revenue gains. Additionally, net revenues were positive for all primary care practices that had at least nine patients in buprenorphine treatment per provider at any given time and no-show rates less than 34 percent. The findings suggest that in the current fee-for-service-dominated environment, offering office-based therapy for opioid addiction with buprenorphine can be a financially sustainable choice for cash-strapped primary care practices, despite hurdles.
-end-
Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model

Sanjay Basu, MD, PhD, et al
Harvard Medical School, Center for Primary Care, Boston, Massachusetts
https://www.annfammed.org/content/18/6/535

American Academy of Family Physicians

Related Buprenorphine Articles from Brightsurf:

Treating opioid addiction in primary care helps patients and cash-strapped medical practices
Buprenorphine-based treatment for opioid addiction is in short supply in many areas of the United States.

Patients' access to opioid treatment cumbersome
The 'secret shopper' study used trained actors attempting to get into treatment with an addiction provider in 10 US states.

Opioid addiction treatment is more widely available, but only for adults
Primary care providers have expanded access to buprenorphine for adults, but use of the opioid addiction treatment has decreased among the youngest patients, find researchers at Columbia University.

Emergency departments slow to adopt proven opioid use disorder therapy
A new study by Yale researchers looking at nearly 400 clinicians at four urban academic emergency departments found that, despite scientific evidence supporting the benefits of buprenorphine for opioid use disorder, just 21% of emergency department clinicians indicated readiness to offer it to patients in need.

Continuity of buprenorphine treatment linked to significantly lower prescription opioid use and over
A study at Columbia University Mailman School of Public Health found that long-term buprenorphine treatment is associated with improvements in health care outcomes.

Financial incentives boost doctor training in opioid treatment medication
Offering $750 to emergency medicine physicians exponentially increased those trained to prescribe buprenorphine.

Nearly one-third of primary care providers do not view medication treatment for opioid use disorder as effective
A new survey of US primary care physicians from researchers at Johns Hopkins Bloomberg School of Public Health found that nearly one-third, 32.9 percent, do not think treating opioid use disorder with medication is any more effective than treatment without medication.

Study reveals pharmacy-level barriers to treatment for opioid use disorder in Appalachian Kentucky
A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD).

Less addictive form of buprenorphine may help curb cocaine relapse
New research performed in mice suggests that chemical modifications to buprenorphine can improve its effectiveness to treat cocaine addiction while minimizing abuse potential.

Residencies must train residents to treat substance use disorder among pregnant women
Early-career family physicians who both provide maternity care and prescribe buprenorphine -- a medication used to treat opioid use disorder -- primarily completed their training in a small number of residency programs.

Read More: Buprenorphine News and Buprenorphine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.